股票 › KLRA
凯莱拉治疗 KLRA
美股市值排名 #2856
$12.97 +$0.80 (+6.57%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $13.31 +2.62%
开盘$12.29
昨收$12.17
当日区间$11.97 – $13.26
成交量733.3K
市值$1.68B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$121.37M-296.0% YoY
净利润-$111.31M-284.5% YoY
摊薄每股收益-$1.09-344.1% YoY
自由现金流-$77.53M-195.6% YoY
经营现金流-$77.53M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
净资产收益率-26.1%
资产收益率-24.1%
投入资本回报率-27.9%
流动比率11.11
负债/资产比率7.7%
现金及投资$916.74M
总负债$9.17M
净现金（净负债）$907.58M
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|---|
| 不影响留存收益的损益 | -$1.79M | -$532,000.00 | $229,000.00 | $0.00 |
| -一年内到期融资租赁负债 | $1.05M | $1.03M | $1.04M | $509,000.00 |
| 其他流动负债 | $721,000.00 | $722,000.00 | $916,000.00 | $2.16M |
| 留存收益 | -$558.84M | -$447.53M | -$368.67M | -$219.71M |
| 资本公积 | $1.68B | $15.98M | $11.98M | $941,000.00 |
| -优先股 | $0.00 | – | – | – |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 |
| 股东权益 | $1.12B | -$432.09M | -$356.46M | -$218.77M |
| 股东权益合计 | $1.12B | -$432.09M | -$356.46M | -$218.77M |
| 其他非流动负债 | $135,000.00 | $201,000.00 | $270,000.00 | – |
| 可转换优先证券 | $0.00 | $992.36M | $992.36M | $390.31M |
| -长期融资租赁负债 | $9.17M | $9.44M | $9.71M | $0.00 |
| 长期债务及融资租赁负债 | $9.17M | $9.44M | $9.71M | $0.00 |
| 非流动负债合计 | $9.30M | $1.00B | $1.00B | $390.31M |
| 固定资产净值 | $11.65M | $12.02M | $12.42M | $680,000.00 |
| 非流动资产合计 | $282.25M | $94.44M | $134.76M | $834,000.00 |
| 其他流动资产 | $395,000.00 | $360,000.00 | $1.23M | $343,000.00 |
| 预付资产 | $5.92M | $7.57M | $7.52M | $2.09M |
| -应计应收利息 | $6.11M | $3.21M | $2.73M | $0.00 |
| 应收款 | $6.11M | $3.21M | $2.73M | $0.00 |
| -短期投资 | $786.44M | $407.35M | $385.79M | $0.00 |
| -现金及现金等价物 | $130.30M | $111.83M | $160.27M | $175.18M |
| 现金及现金等价物与短期投资 | $916.74M | $519.17M | $546.06M | $175.18M |
| 流动资产合计 | $929.17M | $530.32M | $557.54M | $177.61M |
| 总资产 | $1.21B | $624.76M | $692.29M | $178.45M |
| -固定资产原值 | $11.65M | $12.02M | $12.52M | $733,000.00 |
| 投资及预付款 | $255.08M | $62.75M | $106.67M | $0.00 |
| -可供出售证券 | $255.08M | $62.75M | $106.67M | – |
| 短期债务及融资租赁负债 | $1.05M | $1.03M | $1.04M | $509,000.00 |
| 一年内应计费用 | $54.29M | $41.33M | $27.87M | $412,000.00 |
| -应付账款 | $19.20M | $7.10M | $7.53M | $2.01M |
| 应付款 | $19.20M | $7.10M | $7.53M | $2.01M |
| 流动负债合计 | $83.65M | $54.84M | $46.41M | $6.91M |
| 负债合计 | $92.95M | $1.06B | $1.05B | $397.22M |
| 其他非流动资产 | $851,000.00 | $6.35M | $3.48M | $154,000.00 |
| 一年以上预付资产 | $14.67M | $13.32M | $12.19M | $0.00 |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 |
| -累计折旧 | – | – | -$100,000.00 | -$53,000.00 |
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 营业费用 | $121.37M | $84.66M | $158.34M | $30.65M | $20.46M |
| 销售及管理费用 | $20.31M | $13.79M | $49.23M | $11.13M | $10.33M |
| -管理费用 | $20.31M | $13.79M | $49.23M | $11.13M | $10.33M |
| 研发费用 | $101.06M | $70.87M | $109.11M | $19.52M | $10.13M |
| 营业利润 | -$121.37M | -$84.66M | -$158.34M | -$30.65M | -$20.46M |
| 非经营性利息净收入（支出） | $9.99M | $5.72M | $11.05M | $2.13M | $1.68M |
| 非经营性利息收入 | $9.99M | $5.72M | $11.05M | $2.13M | $1.68M |
| 其他收入（支出） | $72,000.00 | $79,000.00 | -$1.66M | -$422,000.00 | $800,000.00 |
| 其他非经营性收入（支出） | $72,000.00 | $79,000.00 | -$1.66M | -$422,000.00 | $800,000.00 |
| 税前利润 | -$111.31M | -$78.87M | -$148.96M | -$28.95M | -$17.98M |
| 净利润 | -$111.31M | -$78.87M | -$148.96M | -$28.95M | -$17.98M |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 持续经营利润 | -$111.31M | -$78.87M | -$148.96M | -$28.95M | -$17.98M |
| 归属母公司净利润 | -$111.31M | -$78.87M | -$148.96M | -$28.95M | -$17.98M |
| 归属普通股股东净利润 | -$111.31M | -$78.87M | -$148.96M | -$28.95M | -$17.98M |
| 基本每股收益 | -$1.09 | -$0.67 | -$1.26 | -$0.25 | -$0.15 |
| 摊薄每股收益 | -$1.09 | -$0.67 | -$1.26 | -$0.25 | -$0.15 |
| 特殊收益（费用） | – | – | $0.00 | – | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 持续经营净利润 | -$111.31M | -$78.87M | -$148.96M | -$28.95M | -$17.98M |
| 持续经营经营活动现金流净额 | -$77.53M | -$68.31M | -$120.21M | -$26.23M | -$18.20M |
| 其他筹资费用净额 | -$1.84M | -$3.04M | -$315,000.00 | – | – |
| 折旧、折耗与摊销 | $101,000.00 | $101,000.00 | $310,000.00 | $62,000.00 | $63,000.00 |
| 其他非现金项目 | $280,000.00 | $274,000.00 | $660,000.00 | $263,000.00 | -$20,000.00 |
| 营运资金变动 | $26.72M | $7.47M | $16.78M | $1.35M | -$984,000.00 |
| -预付资产变动 | -$2.64M | -$1.09M | -$20.94M | -$3.50M | -$2.67M |
| -应付账款及应计费用变动 | $27.39M | $8.88M | $37.99M | $5.31M | $1.70M |
| -其他流动资产变动 | $2.29M | $27,000.00 | -$143,000.00 | -$160,000.00 | -$10,000.00 |
| 投资活动现金流净额 | -$571.02M | $22.85M | -$492.60M | -$74.17M | -$54.44M |
| 持续经营投资活动现金流净额 | -$571.02M | $22.85M | -$492.60M | -$74.17M | -$54.44M |
| 投资购置及出售净额 | -$571.02M | $22.85M | -$490.51M | -$74.17M | -$54.44M |
| 筹资活动现金流 | $667.03M | -$2.98M | $598.66M | $100.00M | $0.00 |
| 持续经营筹资活动现金流净额 | $667.03M | -$2.98M | $598.66M | $100.00M | $0.00 |
| 股票期权行使所得 | $430,000.00 | $57,000.00 | $100,000.00 | $0.00 | $0.00 |
| 自由现金流 | -$77.53M | -$68.31M | -$122.30M | -$26.23M | -$18.20M |
| 期末现金余额 | $131.06M | $112.59M | $161.03M | $102.13M | $102.54M |
| 现金净变动 | $18.48M | -$48.44M | -$14.15M | -$403,000.00 | -$72.64M |
| 经营活动现金流 | -$77.53M | -$68.31M | -$120.21M | -$26.23M | -$18.20M |
| 期初现金余额 | $112.59M | $161.03M | $175.18M | $102.54M | $175.18M |
| -其他流动负债变动 | -$321,000.00 | -$351,000.00 | -$130,000.00 | -$301,000.00 | $0.00 |
| 固定资产购置及出售净额 | – | – | -$2.09M | – | – |
| 债务发行及偿还净额 | – | – | $100.00M | – | – |
| 优先股发行净额 | – | – | $498.87M | – | – |
暂无评论——快来第一个聊聊 KLRA。
登录后参与讨论。